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The Memorial of Professor Marek Pawlicki
On March 4, 2018, Professor Marek Pawlicki passed 
away — a teacher of many of us, a passionate scientist, 
one of the doyens of Polish oncology creating in the 
20th century the foundations of chemotherapy and 
clinical oncology in Poland. He was extraordinary, very 
emotional man with expressive (often controversial) 
opinions. However, first and foremost I remembered 
him as a physician with a great clinical intuition, devoted 
to development of new treatment methods and guided by 
the principle “never take the patient away from hope”. 
Marek Pawlicki was born on July 12, 1934 in Poznan. 
He spent his early childhood in Września, and from 
1940 he lived in Kraków, where in 1951 he graduated 
from Priest Stanislaw Konarski Secondary School. In 
1957 he graduated from medical studies and obtained 
a doctor’s diploma at the Medical Academy in Krakow 
(currently Collegium Medicum of the Jagiellonian 
University). His entire professional life was associated 
with the Krakow Branch of the Centre of Oncology, 
where Professor Pawlicki worked uninterruptedly for 
46 years. He started working at the Oncology Centre 
straight after graduation in January 1958 and continued 
until he reached retirement age in December 2004. The 
first years of his work Professor Pawlicki spent at the 
Oncology Clinic, under the direction of Professor 
Halina Glińska. In 1967 he obtained the title of Doctor 
of Medicine, defending his doctoral dissertation about 
the results of oral cancer treatment. In the 1970s, his 
professional interests began to focus on innovative at 
that time methods of systemic treatment: chemotherapy 
and the first attempts of pharmacological hormone 
therapy. Therefore, in 1974, when the Department of 
General Oncology was divided, he became the Head of 
the Chemotherapy Department of the Krakow Branch 
of the Centre of Oncology. Doctor Marek Pawlicki cre-
ated this clinic from scratch and defined its character 
as preliminary investigating and introducing the new 
methods of treatment. Therefore, soon after setting up 
this clinic become one of the most important chemo-
therapy units in Poland. Future specialists of cancer 
chemotherapy, often from faraway corners of Poland, 
came to internships to learn under his direction and 
familiarize themselves with new therapies. 
Doctor Marek Pawlicki participated as a researcher 
in dozens of clinical trials devoted to new treatment 
methods of cancers and their symptoms. The effect of 
this passion was about 260 publications in both Polish 
and international journals. In addition to research about 
new forms of therapy, he was interested in the causes of 
delays in cancer diagnosis and treatment as well as the 
relationship between oncology and alternative medicine 
therapies used by patients. 
Dr Marek Pawlicki’s scientific work resulted in habili-
tation thesis on the role of chemotherapy and hormone 
therapy in breast cancer management, which he defended 
in 1979. In April 1988 he was appointed professor. Profes-
sor Pawlicki directed the chemotherapy clinic until the 
end of his career at the Centre of Oncology in December 
2004. Professor Pawlicki’s passion was also spreading 
oncological knowledge; he was a co-author of therapeutic 
recommendations and over 10 books: mainly textbooks, 
but also popular science publications as well as memories 
of his oncologist’s work. He was one of the first editors 
and founders of the „Oncology in Clinical Practice” 
journal and a reviewer of numerous scientific papers 
and doctorates. For many years he organized courses for 
specialization in cancer chemotherapy and oncology as 
well as oncological lectures for primary care physicians; 
he also participated in specialization examinations. He 
educated many specialists in chemotherapy and clinical 
oncology, he was the promoter of several doctoral dis-
sertations, and many of the consultants and current head 
of the departments of clinical oncology are his students.
That’s about just facts; but for us, his colleagues, 
much more important is the mere mention of style of 
work with Professor Pawlicki, methods of treatment 
and decision-making mechanisms used in his Clinic. 
In current medical reality with abundance of available 
therapies, but limitations arising from numerous recom-
mendations and evidence-based medicine it is probably 
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difficult to imagine that specific work climate, with pre-
dominance of clinical trials on new preparations, which 
were often the only available treatment options for our 
patients. During morning briefings (being very often 
brainstorming) under Professor Pawlicki supervision 
new chemotherapy regimens were developed, or the 
old ones modified according to the patient’s individual 
needs. We attempted to use a treatment with all availa-
ble forms of immunotherapy: interferons, BCG, DNCB, 
IL2, metronomic therapy, chronotherapy, high doses of 
etoposide or methotrexate, and many other drugs cur-
rently remembered only by older oncologists. Thanks 
to Professor’s international research contacts, we got 
acquainted with many currently used medicines like 
docetaxel, vinorelbine, liposomal doxorubicin, or pem-
etrexed already at the stage of their clinical trials and 
we participated in pivotal studies. The scientific contacts 
established by the Professor in centres in Milan, Paris or 
Vienna resulted in academic research and internships, 
and often access to information about the latest concepts 
in science already during their creation. 
However, the atmosphere at the clinic was far from 
the cold laboratory or lecture rooms and to a large extent 
it was shaped by Professor’s new ideas and emotional 
personality. As Professor was interested in motor sports 
and football, often during the briefing there were digres-
sions on sports subjects. Professor Pawlicki has been 
repeatedly able to surprise us with remarkable medical 
intuition, both in predicting complications during treat-
ment and in detecting patients with potential psycho-
logical or psychological problems hindering treatment. 
We have not always found a rational justification for his 
intuition and forecasts, which is why it sometimes hap-
pened that we resisted and disbelieved. However, after 
a few episodes confirming that our knowledge cannot 
always compare with Professor’s intuition or knowledge, 
we have learned to trust his predictions.
It is difficult to express all the achievements and 
activities of Professor Marek Pawlicki in these short 
words and describe the richness of his personality. As 
our Teacher and Mentor, Professor will remain forever 
in our memory.
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